Gross Profit Trends Compared: Dr. Reddy's Laboratories Limited vs Pharming Group N.V.

Pharma Giants' Profit Trends: A Decade in Review

__timestampDr. Reddy's Laboratories LimitedPharming Group N.V.
Wednesday, January 1, 20147580100000021595165
Thursday, January 1, 2015854030000006590427
Friday, January 1, 20169228100000011768542
Sunday, January 1, 20177835600000092587038
Monday, January 1, 201876304000000129203843
Tuesday, January 1, 201983430000000165412447
Wednesday, January 1, 202094009000000203056430
Friday, January 1, 2021103077000000169670071
Saturday, January 1, 2022113840000000188060000
Sunday, January 1, 2023202972000000220104000
Monday, January 1, 2024163607000000
Loading chart...

Unveiling the hidden dimensions of data

Gross Profit Trends: A Tale of Two Pharmaceutical Giants

In the ever-evolving pharmaceutical industry, understanding financial trends is crucial. Dr. Reddy's Laboratories Limited and Pharming Group N.V. offer a fascinating comparison of gross profit trends from 2014 to 2023. Dr. Reddy's, a major player in the global market, has shown a robust growth trajectory, with gross profits increasing by approximately 167% over the decade. Notably, 2023 marked a significant leap, with profits nearly doubling from the previous year.

In contrast, Pharming Group N.V., a smaller entity, has experienced a more modest growth, with gross profits increasing by around 920% over the same period. Despite this impressive percentage growth, their absolute figures remain a fraction of Dr. Reddy's. The data for 2024 is incomplete, highlighting the dynamic nature of the industry. This comparison underscores the diverse financial landscapes within the pharmaceutical sector, offering insights into strategic growth and market positioning.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025